Introduction
Introduction Statistics Contact Development Disclaimer Help
Return Create A Forum - Home
---------------------------------------------------------
MS Speaks
https://msspeaks.createaforum.com
---------------------------------------------------------
*****************************************************
MS Speaks
*****************************************************
(ECTRIMS) 2-year Ocrevus effective for early MS patients
0 replies
"Dear MS" Ocrevus commercial
0 replies
(JAMA) 3rd dose of mRNA COVID-19 vaccine in MS patients treate...
0 replies
(Abst.) Mild PML after switching from Tysabri to Ocrevus
0 replies
(Abst.) Clinical outcomes of patients w/MS treated w/Ocrevus...
1 replies
(Abst.) Are disease-modifying drugs for progressive MS worthwh...
0 replies
Immune-suppressed patients in Ontario eligible for earlier COV...
0 replies
Higher severe COVID-19 risk for patients on Ocrevus, Rituxan
1 replies
Fatal PML case in 78-year-old patient on Ocrevus monotherapy
3 replies
(Abst.) Ocrelizumab depletes T-lymphocytes more than rituximab...
0 replies
*****************************************************
Previous Page
Next Page
You are viewing proxied material from gopher.createaforum.com. The copyright of proxied material belongs to its original authors. Any comments or complaints in relation to proxied material should be directed to the original authors of the content concerned. Please see the disclaimer for more details.